Defects in the E2 lipoyl transacetylase and the X-lipoyl containing component of the pyruvate dehydrogenase complex in patients with lactic acidemia.
Three patients with chronic lacticacidemia and deficiency of the pyruvate dehydrogenase complex demonstrated in cultured skin fibroblasts showed abnormalities on Western blotting with anti-pyruvate dehydrogenase complex antiserum which were not located in the E1 (alpha and beta) component of the complex. One of these patients had an enzymatically demonstrable deficiency in the E2 dihydrolipoyl transacetylase segment of the complex and very low observable E2 protein component on Western blotting of fibroblast proteins. The other two patients had abnormalities observable in the X component but no observable reduction in either E1, E2, or E3 enzymatic activities. One patient appeared to have a missing X component while the other had two distinct bands where X should be on Western blotting of fibroblast proteins. All three patients appeared to have severe clinical sequelae resulting from these defects. This is the first time that defects in either the E2 or the X component of the pyruvate dehydrogenase complex have been observed in the human population.
Robinson
B H
BH
Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.
MacKay
N
N
Petrova-Benedict
R
R
Ozalp
I
I
Coskun
T
T
Stacpoole
P W
PW
D000123:Acetyltransferases / Q000172:deficiency*; D000140:Acidosis, Lactic / Q000201:enzymology*; D015153:Blotting, Western; D051047:Dihydrolipoyllysine-Residue Acetyltransferase; D005260:Female; D006801:Humans; D008297:Male; D010455:Peptides / Q000172:deficiency*; D011768:Pyruvate Dehydrogenase Complex; D015325:Pyruvate Dehydrogenase Complex Deficiency Disease
C045867:PDHX protein, human; D010455:Peptides; D011768:Pyruvate Dehydrogenase Complex; D000123:Acetyltransferases; D051047:Dihydrolipoyllysine-Residue Acetyltransferase